Background-Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results-Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs.
O cclusion of coronary arteries results from advanced atherosclerotic lesions or plaque rupture. 1 A common therapy to restore the blood flow in such narrowed arteries is angioplasty. However, endovascular interventions may lead to a long-term risk of restenosis, ie, the remodeling and eventually reocclusion of treated arteries. Although the exact pathogenesis of restenosis is unclear, it is known that after the initial injury smooth muscle cells (SMCs) contribute together with other cell types to the remodeling of the vessel wall.
See accompanying article on page 1207
Nitric oxide (NO) is an important regulator of cardiovascular homeostasis and, in particular, of SMC function. 2 In addition to potent vasorelaxant properties of NO, its bioavailability and signaling have also been associated with vascular proliferative diseases, such as atherosclerosis and restenosis. [3] [4] [5] [6] Studies with transgenic mice that overexpress or lack the NO synthases indicated that NO can mediate beneficial effects on the vasculature under particular pathophysiological conditions. [7] [8] [9] [10] [11] On the other hand, several studies reported that NO promoted the progression of vasculoproliferative processes, and, thus, that it was deleterious for the vasculature. [12] [13] [14] [15] In restenosis, the endogenous effector(s) and underlying molecular mechanism(s) that mediate the opposing effects of NO on vascular remodeling are not clear. Under physiological conditions, NO exerts many of its effects via stimulation of the soluble guanylyl cyclase (sGC), which generates the second messenger cyclic guanosine-3Ј-5Ј-monophosphat (cGMP). The cGMP-dependent protein kinase type I (cGKI) is presumably the major target of NO/cGMP signaling in SMCs. 2 For example, mice with a homozygous deletion of the cGKI gene showed an impaired NO/cGMP-dependent relaxation of SMCs. 16 The role of cGKI has also been implicated in the phenotypic modulation of SMCs, which occurs in atherosclerosis and restenosis. 17, 18 Several studies suggested that activation of cGKI-dependent pathways has antimitogenic effects in SMCs in vitro, 19 -21 and might be vasculo-protective in vivo. 22, 23 Recent evidence suggested that elevation of cGMP by the phosphodiesterase-5 (PDE-5) inhibitor sildenafil, hence, activation of cGMP-dependent pathways, was beneficial for the treatment of hypertrophic heart disease 24 and for vascular remodeling associated with pulmonary hypertension. 25 These findings indicated that particularly activation of cGKI mediated the protective effects of sildenafil in vivo. 26 Surprisingly, the analysis of cGKI-deficient mice produced some evidence that activation of cGKI in SMCs increased the growth of primary SMCs and promoted the formation of atherosclerotic lesions in the apolipoprotein E (apoE)-deficient mouse model of hyperlipidemia-induced atherosclerosis. 27 These results supported a unique proatherogenic potential of SMC cGKI in atherosclerosis, 18 whereas the direct role of endogenous cGMP/cGKI signaling in restenosis, to our knowledge, was not tested before.
In the present study, we addressed the question whether the cGMP/cGKI pathway in SMCs is also involved in the vascular pathology of restenosis. The Cre/loxP system was used to generate mice with a tissue-specific deletion of the cGKI gene in SMCs. To test the pathophysiological role of endogenous cGKI 2 established mouse models, which resemble restenosis in humans, were used: the unilateral cessation of blood flow by carotid ligation 28 and the removal of the endothelium by wire-injury of the carotid artery. 29 
Materials and Methods
Detailed methods are described in the supplemental data (available online at http://atvb.ahajournals.org).
Experimental Animals
The SM22␣-Cre mouse line 30 was crossed to mice that carried loxP-flanked cGKI alleles (L2) 31 to generate cGKI mutants with recombined cGKI-null alleles (L-). The tissue-specific knockout of the cGKI gene was generated in cardiac and smooth muscle cells ). All animals were maintained and bred in the animal facility of the Institut für Pharmakologie und Toxikologie, Technische Universität München and had access to water and standard chow ad libitum. All experimental procedures were conducted according to the local government's committee on animal care and welfare in München.
Carotid Artery Ligation
The injury procedure was performed by adapting an established model. 28 Briefly, the left common carotid artery of deeply anesthetized animals was dissected and completely ligated proximal to its bifurcation.
Endothelial Denudation
Surgery was performed as described previously. 29 Endothelial denudation of the left common carotid artery was performed by withdrawal injury passing a 0.014 inch flexible angioplasty guide wire 3 times trough the vessel. This method very efficiently removed the endothelium.
Results

Tissue-Specific Deletion of cGKI in SMCs
The recombination properties, in particular the tissue-specificity, of the SM22␣-Cre mouse line (SM22␣-Cre) 30 were evaluated by crossing Cre transgenic animals to ROSA26 Cre reporter (R26R) mice. 32 X-Gal staining of tissues from SM22␣-Cre; R26R reporter mice for ␤-galactosidase activity demonstrated recombination in the heart (Figure 1a ) and in the common carotid artery (CCA; Figure 1b) , whereas with the exception of cardiomyocytes, no staining could be detected in all non-SMC tissues analyzed (data not shown). At the cellular level, blue staining was visible in vascular SMCs of the medial cell layer of the uninjured CCA (Figure 1c ). In addition, recombination in the SM22␣-Cre; R26R reporter mice was analyzed 28 days after carotid ligation. At this time point, severe morphological changes were apparent in the ligated vessel. Inside the internal elastical lamina (IEL), a prominent neointima (NI) had formed. As shown by X-gal staining of ligated vessels, recombination was detectable in the media and importantly became manifest in cells of the NI as well (Figure 1d ). These results demonstrated that Cre activity in the SM22␣-Cre mouse line is restricted to cardiomyocytes and SMCs and that the recombination efficiency in medial SMCs of the CCA as well as in NI forming cells after injury is very high.
A cGKI-null allele (L-) in SMCs was generated by crossing the SM22␣-Cre mouse line to mice carrying a conditional loxP-flanked cGKI allele (L2). 31 Cre-mediated recombination of the loxP sites and the resulting L-allele was detectable by polymerase chain reaction (PCR) analysis of genomic DNA in SMC-containing tissues and in the heart (supplemental Figure I ). Importantly, recombination of the L2 to the L-allele was highly efficient in the CCA and the aorta, less efficient in heart, and not detectable in non-smooth muscle tissue. Western blot analysis demonstrated that the level of cGKI protein was strongly reduced in the CCA and aorta, moderately reduced in the heart, and not altered in the cerebellum (Figure 2a ). The decrease in cGKI protein levels in the hearts of the cGKI csmko mice might result from both a transient SM22␣ promotor fragment activity and subsequent Cre expression in the embryonic cardiomyocyte lineage 33 as well as from a persistent expression of the Cre transgene in coronary SMCs. In uninjured control animals, immunohistochemical analysis of the CCA (Figure 2b ) and aorta (data not shown) using specific antibodies 34 revealed a strong and uniform expression of the cGKI protein in the medial layer. At 28 days after ligation of the left CCA from control animals, the cGKI protein was expressed in the media and, in addition, it was detectable in cells of the neointima (NI) ( Figure 2b ). However, the heterogeneous expression pattern observed in the NI probably resulted from both a restricted downregulation of cGKI in some media derived SMCs that switched from the contractile to a more synthetic/proliferative phenotype, 17 and the contribution of cGKI-negative nonSMCs to the NI formation. In cGKI csmko mutants, no cGKI staining could be identified in the uninjured CCA and 28 days after carotid ligation (Figure 2b) . Thus, the genetic strategy via Cre/loxP-mediated somatic mutagenesis resulted in an efficient ablation of the cGKI protein from the uninjured and injured CCA. However, under normal conditions the cGKI csmko mice were healthy and showed no gross phenotypic abnormalities as demonstrated by their long term survival rates and a normal gastrointestinal transit time (supplemental Figure II) . Importantly, the arterial morphology and vessel structure as analyzed by the expression of several cGKI substrates and SMC marker proteins showed no significant differences between both genotypes before vascular injury (supplemental Figure III) . In addition, the basal levels of endogenous cAMP (supplemental Figure IVa) and cGMP (supplemental Figure IVb) of control and cGKI csmko vascular SMCs were similar. In both genotypes treatment of vascular SMCs with sildenafil (0.1 mmol/L) or the NO-donor DEA-NO (0.1 mmol/L) increased cGMP-levels by Ϸ20 and Ϸ80-fold respectively, whereas cAMP levels showed no significant changes (supplemental Figure IV) . Thus, the genetic approach to abolish cGKI activity in vascular SMCs did not affect endogenous cyclic nucleotide levels. In addition, the 8-Br-cAMP-stimulated phosphorylation of VASP at Ser157, a common phosphorylation site for both cGKI-and cAMP-dependent kinases (cAKs), was detectable in primary vascular SMCs of control as well as cGKI csmko mice ( Figure  3) . However, the 8-Br-cGMP-stimulated phosphorylation of substrate proteins was clearly impaired in vascular SMCs of the cGKI csmko as demonstrated by the use of phospho-specific antibodies ( Figure 3 ). These results support the conclusion that vascular SMCs of tissue-specific cGKI csmko mice lack cGKI activity.
Vascular Remodeling After Carotid Ligation
Ligation of the left CCA induced intensive remodeling of the injured vessel segment in both control (genotype: SM22␣-Cre tg/ϩ ; cGKI
) and cGKI csmko (genotype: SM22␣-Cre tg/ϩ ; cGKI L-/L2 ) mice. The histological analysis of hematoxylin and eosin (H&E)-stained sections showed the formation of a neointima within the IEL, but no obvious differences were found between the genotypes 28 days after injury (supplemental Figure Va) . The presence of an intact endothelial cell layer on the luminal surface of the ligated vessels was demonstrated by immunoreactivity for the von Willebrand factor (vWF) at all time-points analyzed (data not shown). The positive vWF stain confirmed the existence of endothelial cells after injury, and, therefore, it was anticipated that the endothelial sources of NO were preserved during the entire injury period. Furthermore, by studying knockout mice it was shown before that loss of NO derived from the NO synthase (NOS) isozymes had a major impact on the remodeling process in the ligation model. 9, 35 Quantitative assessment of the remodeling response was performed by morphometric analysis on H&E stained sections. Based on the mean NI/media ratios, no differences The antibodies used to detect cGKI substrate phosphorylation were specific for phosphoSer239 of the vasodilator-stimulated phosphoprotein (pVASP 239 ) and the phospho-Ser92 residue of phosphodiesterase-5 (pPDE-5). A VASP common antibody was used, which detects both total VASP (lower band) and the cAK and cGKI phosphorylation site of VASP at serine 157 (VASP 157 ). A PDE-5 antibody was used on the same protein homogenates to demonstrate equal loading of the gels.
could be detected between control mice (NI/media ratio 0.38Ϯ0.06; nϭ22) and littermate cGKI csmko mice (NI/media ratio 0.45Ϯ0.08; nϭ10) 28 days after injury ( Figure 4a ). As expected, the extent of remodeling was less intensive after 14 days, but again no differences could be detected between both groups (ctr NI/media ratio 0.12Ϯ0.03; nϭ18; cGKI csmko NI/ media ratio 0.14Ϯ0.04; nϭ13; Figure 4a ). To test whether an activation of the cGMP/cGKI pathway after injury had consequences for the vascular response to ligation, a control group of animals (genotype: SM22␣-Cre tg/ϩ ; cGKI ϩ/L2
) was continuously treated with sildenafil in their drinking water. As determined by the NI/media ratio 28 days after injury, no significant difference was detected between animals treated with sildenafil (NI/media ratio 0.29Ϯ0.10; nϭ10) and the untreated control mice (Figure 4a ), although cGMP levels were effectively elevated in the drug-treated mice (supplemental Figure Vb) .
To focus on possible local consequences of the cGKI inactivation, continuous NI/media profiles of the injured arteries were generated ( Figure 4b ). These profiles revealed a gradual decline of the NI/media ratio with increasing distance to the point of ligation and confirmed a similar response to injury of control and cGKI csmko animals. Additional vessel parameters, such as the area inside the external elastic lamina (EEL) ( (Figure 4c ). All vascular parameters were also determined after 14 days of injury, but again they were similar for both genotypes (data not shown).
As shown previously, proliferation of cells from the vessel wall was involved in the remodeling after vascular injury. 28 To assess this issue, the density of a proliferation marker was evaluated in the remodeled vessel (supplemental Figure Vc) . The percentage of positive stained cells in the NI and the medial cell layer was comparable between genotypes. This result indicated that proliferation of cells from the vessel wall contributed to remodeling, but the deletion of cGKI in SMCs showed again no influence.
Earlier reports suggested that SMC cGKI modulated the progress of atherogenesis. 27 It was possible that a contribution of cGKI to vascular remodeling after mechanical injury required factors that are present in atherosclerosis-prone mice. Therefore, we reinvestigated vascular remodeling in apoE-deficient (apoE-ko) mice using the above model of CCA ligation. The morphometric data based on measurements of the NI/media ratio (apoE-ko ctr NI/media ratio 0.59Ϯ0.09; nϭ13 and littermate apoE-ko cGKI csmko NI/media ratio 0.79Ϯ0.15; nϭ12; Figure 5a) ; apoE Ϫ/Ϫ ; nϭ13) and cGKI csmko mice (csmko apoE-ko; SM22␣-Cre tg/ϩ ; cGKI L-/L2
; apoE Ϫ/Ϫ ; nϭ12) are shown. b, Analysis of the ligation-induced changes of the external elastic lamina (EEL), media, neointima (NI), and lumen by morphometry. No differences were detectable between control mice (dark gray circles and bars; nϭ13) and cGKI csmko mutants (light gray circles and bars; nϭ12) on an apoE-deficient background. ; nϭ12) revealed that both genotypes responded equally to the ligation (Figure 5b ). As shown before in the NI and media of normolipedemic mice, the cGKI protein was expressed 28 days after injury in apoE-deficient control mice, and this expression pattern was abolished in apoE-deficient cGKI csmko mutants (supplemental Figure VI) . Thus, the comparable remodeling responses of apoE-deficient control and cGKI csmko mice did not result from an inadequate recombination efficiency of the SM22␣-Cre transgene because vascular cGKI was absent in the mutants. We cannot exclude that the lack of cGKI during ontogenesis in the present injury model perhaps led to an undetected functional compensation of the pathway, whereas in the atherosclerosis model, a tamoxifeninducible Cre was used to delete cGKI selectively only in SMCs of adult mice that were fed an atherogenic diet. 27 Vascular Remodeling After Wire-Injury of the CCA All experiments shown so far used ligation of the left CCA. It was therefore hypothesized that the inability to detect an effect of SMC cGKI on vascular remodeling was perhaps caused by the presence of an "intact" endothelium. We therefore removed the endothelium by the wire-injury procedure. 29 In line with the abolished cGKI expression pattern observed in ligated vessels of cGKI csmko mutants, no cGKI protein was expressed in the cGKI csmko 28 days after wireinjury (supplemental Figure VII) . The data based on a detailed analysis of the NI/media ratio profile (Figure 6a ) and all morphometric parameters of the remodeled vessel ( Figure  6b) were similar between genotypes after denudation. However, in a small region at approximately 1.4 to 1.8 mm distance from the bifurcation, the detailed analysis of the profiles revealed a restricted but statistically significant decrease in the NI/media ratios of the cGKI csmko mutant mice.
Discussion
Recent analysis of vascular proliferative disorders in cGKI mouse mutants indicated that smooth muscle cGKI accelerates plaque formation in a hyperlipidemia-induced model of atherosclerosis. 27 These results suggested that cGKI in SMCs potentially mediates proatherogenic properties of the NO/ cGMP pathway in vivo, being thus, in contrast to the common view, not vasculoprotective. To solve the controversy whether the cGMP/cGKI pathway in SMCs accelerates lesion formation or mediates vascular protection, we generated different models of vascular restenosis. In comparison to control mice, we could not detect any influences of the cGKI deletion in SMCs on the NI/media ratio, proliferation, and various other vessel parameters at different time-points after injury in normolipedemic and in apoE-deficient mice. In line with these results, activation of the cGMP/cGKI pathway by chronic administration of sildenafil had no influence on the remodeling response after carotid ligation. Further, no potentially vasculoprotective effects of endogenous cGKI on the remodeling were observed in the absence of a functional endothelium. Interestingly, the tissue-specific deletion of cGKI in SMCs had a minor beneficial impact after wireinjury in a spatially restricted vessel segment. The inability of smooth muscle cGKI to affect remodeling was not caused by an altered distribution of the enzyme between media and NI. Previous analysis of the NI formation after balloon injury of rat carotid arteries showed that the media and the NI express cGKI after injury. 36 These results implied a potential role of the cGMP/cGKI pathway for injury-induced remodeling, and identical data have been obtained in the present study. Neither genetic nor pharmacological manipulation of cGMP/cGKI signaling indicate that smooth muscle cGKI is of major importance during mechanically-induced restenosis of murine vessels. It has been suggested that the effects of NO are strongly concentration-dependent. Presumably, the spatio-temporal profile, the amount of NO synthesized, and the source of its production after vascular injury result in the activation of alternative mechanisms that are not mediated by cGKI or cGMP, such as redox regulation of target proteins. 37, 38 It has been reported recently that cGMPindependent redox regulation of the sarcoplasmatic reticulum calcium ATPase (SERCA) might be required for NO inhibition of SMC migration after arterial injury. 39 The cGMP/cGKI pathway has been previously evaluated in models that differ from the ligation model. In rat the balloon injury model has been used to examine the contribution of cGMP and cGKI to the restenosis process. 23, 40, 41 Adenoviral transfer of a constitutively active kinase domain of cGKI 23 and sGC 41 in conjunction with the application of the NO-donor molsidomine reduced significantly the proliferation of cells in the NI. In contrast, adenoviral overexpression of the full-length cGKI␤ isoform did not affect restenosis induced by balloon injury. 23 In the same model, YC-1, an activator of sGC, prevented NI formation. 40 In these studies endogenous cGMP levels after drug treatment were not determined, and it was not clear whether or not the observed effects were cGMP-dependent. Interestingly, it was shown recently that YC-1 activates matrix metalloproteinases thereby inhibiting neointima formation in a cGMPindependent manner. 22 Together, the pharmacological and genetic approach used in the present work differs significantly from balloon injury in conjunction with adenoviral gene transfer.
In conclusion, the present study demonstrated that neither a deletion of cGKI in SMCs nor an activation of the cGMP/cGKI pathway through pharmacological PDE-5 inhibition impaired the overall vascular remodeling after carotid ligation in normolipidemic and apoE-deficient or wireinjured mice. All experimental approaches tested the influence of endogenous SMC cGKI on vascular remodeling by locally restricted injuries resembling restenosis, whereas the analysis of atherosclerosis identified a proatherogenic role of SMC cGKI for systemic vessel disease. 27 Based on the presented results, we conclude that the well-accepted effects of NO in restenosis 35 are independent of smooth muscle cGKI and that the contribution of cGKI-mediated mechanisms to vascular remodeling appears to be context-specific, being more important in atherosclerosis than in restenosis.
